KR890701139A - Tc-99m 방사성의약품의 제조 - Google Patents

Tc-99m 방사성의약품의 제조

Info

Publication number
KR890701139A
KR890701139A KR1019890700039A KR890700039A KR890701139A KR 890701139 A KR890701139 A KR 890701139A KR 1019890700039 A KR1019890700039 A KR 1019890700039A KR 890700039 A KR890700039 A KR 890700039A KR 890701139 A KR890701139 A KR 890701139A
Authority
KR
South Korea
Prior art keywords
complex
ligand
halide
general formula
tco
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019890700039A
Other languages
English (en)
Korean (ko)
Inventor
앤드류 라탐 아이안
리챠드 쏜백 존
레슬리 뉴우만 조안
Original Assignee
원본미기재
아머샴 인터내셔날 피이엘씨이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 아머샴 인터내셔날 피이엘씨이 filed Critical 원본미기재
Publication of KR890701139A publication Critical patent/KR890701139A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005—Compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Developing Agents For Electrophotography (AREA)
KR1019890700039A 1987-05-15 1988-05-16 Tc-99m 방사성의약품의 제조 Withdrawn KR890701139A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB8711496 1987-05-15
GB878711496A GB8711496D0 (en) 1987-05-15 1987-05-15 Tc-99m radiopharmaceuticals
PCT/GB1988/000383 WO1988008720A1 (en) 1987-05-15 1988-05-16 Preparation of tc-99m radiopharmaceuticals

Publications (1)

Publication Number Publication Date
KR890701139A true KR890701139A (ko) 1989-12-19

Family

ID=10617388

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890700039A Withdrawn KR890701139A (ko) 1987-05-15 1988-05-16 Tc-99m 방사성의약품의 제조

Country Status (13)

Country Link
US (1) US5081232A (https=)
EP (1) EP0291281B1 (https=)
JP (1) JPS6452787A (https=)
KR (1) KR890701139A (https=)
AT (1) ATE65917T1 (https=)
AU (1) AU603443B2 (https=)
CA (1) CA1323484C (https=)
DE (1) DE3864071D1 (https=)
ES (1) ES2039279T3 (https=)
GB (1) GB8711496D0 (https=)
IL (1) IL86388A0 (https=)
WO (1) WO1988008720A1 (https=)
ZA (1) ZA883451B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001979A (en) 1989-08-29 1999-12-14 Nycomed Amersham Plc Cores for technetium radiopharmaceuticals
US5744120A (en) * 1993-03-30 1998-04-28 The Dupont Merick Pharmaceutical Company Ternary radiopharmaceutical complexes
US5961952A (en) * 1996-01-24 1999-10-05 Dupont Pharmaceuticals Company 99m Tc-tertiary-butyl isonitrile as breast tumor imaging agents
GR1003191B (el) * 1998-01-13 1999-10-29 ������ ������ ������� ������� ��������� ����������.... Μεθοδος, συνθεση προσκευασματος (κιτ) και προσκευασμα (κιτ) για τη παρασκευη σε ενα σταδιο του συμπλοκου τεχνητιο 99μ (v) διμερκαπτοηλεκτρικο οξυ, για τη διαγνωση του μυελοειδους καρκινωματος του θυρεοειδους καθως και διαφορων ογκων
CA3263646A1 (en) * 2022-07-29 2024-07-18 Curium Us Llc [177lu] lutetium-psma l&t composition, kit, method of making, and method of using thereof
WO2025029946A1 (en) 2023-07-31 2025-02-06 Curium Us Llc [177lu] lutetium-psma i&t composition and dosimetry, kit, method of making, and method of using thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4489054A (en) * 1980-04-18 1984-12-18 Research Corporation Cationic lipophilic complexes of 99m Tc and their use for myocardial and hepatobiliary imaging
US4387087A (en) * 1980-04-18 1983-06-07 Research Corporation Cationic lipophilic complexes of 99m Tc and their use for myocardial and hepatobiliary imaging
US4451450A (en) * 1981-10-15 1984-05-29 New England Nuclear Corporation Cationic compounds useful for making radiodiagnostic agents
US4374821A (en) * 1982-06-28 1983-02-22 E. R. Squibb & Sons, Inc. Myocardial imaging agent and method
US4481184A (en) * 1983-02-14 1984-11-06 E. R. Squibb & Sons, Inc. Cationic technetium (I) complexes
US4526776A (en) * 1983-04-15 1985-07-02 E. I. Du Pont De Nemours & Company Cationic cyanato and thiocyanato complexes useful as radiodiagnostic agents
DE3484511D1 (de) * 1983-12-29 1991-05-29 Commw Of Australia Herstellung von mit 99m tc markierten radioarzneimitteln.
US4707544A (en) * 1984-11-28 1987-11-17 President And Fellows Of Harvard College Metal-isonitrile adducts for preparing radionuclide complexes for labelling and imaging agents

Also Published As

Publication number Publication date
US5081232A (en) 1992-01-14
ZA883451B (en) 1989-01-25
JPH0576953B2 (https=) 1993-10-25
GB8711496D0 (en) 1987-06-17
ATE65917T1 (de) 1991-08-15
EP0291281A1 (en) 1988-11-17
CA1323484C (en) 1993-10-26
WO1988008720A1 (en) 1988-11-17
AU1615288A (en) 1988-11-17
JPS6452787A (en) 1989-02-28
DE3864071D1 (de) 1991-09-12
IL86388A0 (en) 1988-11-15
EP0291281B1 (en) 1991-08-07
ES2039279T3 (es) 1993-09-16
AU603443B2 (en) 1990-11-15

Similar Documents

Publication Publication Date Title
Clarke et al. Nitrogen-bound and carbon-bound xanthine complexes of ruthenium ammines
US4374821A (en) Myocardial imaging agent and method
JP3741716B2 (ja) トリ（白金）錯体
Bennett et al. Electronic and infrared spectral study of chromium (III) derivatives of the type [Cr (NCS) 4.(ligand) 2]-
KR890701139A (ko) Tc-99m 방사성의약품의 제조
Schwarz et al. Mono-, di-and trinuclear Pt (II), mononuclear Pt (IV), mixed Pt (II), Pt (IV), mixed Pt (II), Ag (I) complexes of 9-methyladenine (9-MeA), and the X-ray structure of [(dien) Pt (9-MeA-N1)](NO3) 2· H2O
De Donno et al. Studies of a fifteen-membered tetraphosphorus macrocyclic ligand
Chen et al. Interconversion between S-and N-bound L-methionine adducts of Pt (dien) 2+(dien= diethylenetriamine) via dien ring-opened intermediates
Groß et al. Diphosphate− Zinc Complexes with Tridentate Coligands
Kukushkin et al. Hydrolysis of organonitriles and carboxamides in platinum (IV) complexes. X-ray structure determination of the crystalline clathrate {(C2H5)} 4N [Pt (NH3) Cl5]· 16 NH4Cl
Atkinson et al. Synthesis and characterization of compounds of di-and tributyltin chloride with adenine and guanine mononucleotides
Mikuriya et al. Unexpected coordination behavior of dinucleating ligand: infinite zigzag chain of alternating sodium (I) and dinuclear-zinc (II) units
Pruchnik et al. Butyltin (IV) citrates and tartrates: structural characterization and their interaction with nucleotides
Bose et al. Characterization of platinum (II)-phosphato complexes of uridine nucleotides
Fujii An NMR Study of Metal Complexes Containing Acetylacetone and Related Compounds. IV. The NMR Spectra and the Ligand-exchange Reaction of Cobalt (III) Complexes Containing N, N′-Ethylenebis (acetylacetonimine) and Amino Acid
Ghosh et al. Anation reactions of cobalt (III) complexes
Arpalahti et al. Facile Preparation of PtII‐Nucleobase Monoadducts with trans Geometry: Structural Characterization and Kinetics for Cl− Hydrolysis Reactions of trans‐[PtCl (NH3) 2 (L‐N7)] n+ (L= 9‐Methyladenine or 9‐Methylhypoxanthine)
Salem et al. Stereochemistry and dynamic properties of square-planar and square-pyramidal cations of bivalent nickel, palladium, and platinum containing the enantiomers of (R*, R*)-(.+-.)-and (R*, S*)-(.+-.)-1-(methylphenylarsino)-2-(methylphenylphosphino) benzene
WO1989012640A1 (en) Technetium (iii/ii) imaging agents
Yamaguchi et al. Asymmetric transformation of. alpha.-amino acids promoted by optically active cobalt (III) complexes. 3. Importance of side-chain intramolecular interligand hydrogen bonding on stereoselectivity
Abbott et al. Carbon-13 and phosphorus-31 NMR studies of interactions of organorhodium complexes with guanosine, inosine, 6-mercaptoguanosine, and 8-mercaptoguanosine in neutral and basic dimethyl-d6 sulfoxide solutions
Gillard Analogies between coordination and quaternization of imines, including N-heterocycles
Mulliez et al. First evidence for a curtius type rearrangement involving a charged atom. An easy synthesis of an iminophosphonium salt
Noufele Uranium and Thorium Complexes with Aroylbis (N, N-dialkylthioureas)
ATE123228T1 (de) Myokardgängige technetium-komplexverbindungen und verfahren zu deren herstellung.

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19890111

PG1501 Laying open of application
PC1202 Submission of document of withdrawal before decision of registration

Comment text: [Withdrawal of Procedure relating to Patent, etc.] Withdrawal (Abandonment)

Patent event code: PC12021R01D

Patent event date: 19921019

WITB Written withdrawal of application